Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 264

1.

New factors for protein transport identified by a genome-wide CRISPRi screen in mammalian cells.

Bassaganyas L, Popa SJ, Horlbeck M, Puri C, Stewart SE, Campelo F, Ashok A, Butnaru CM, Brouwers N, Heydari K, Ripoche J, Weissman J, Rubinsztein DC, Schekman R, Malhotra V, Moreau K, Villeneuve J.

J Cell Biol. 2019 Sep 5. pii: jcb.201902028. doi: 10.1083/jcb.201902028. [Epub ahead of print]

PMID:
31488582
2.

A public health enhanced surveillance system for a mass gathering event.

Huot C, Paradis A, Hammond-Collins K, Bélair MA, Villeneuve J, Brousseau N, Goupil-Sormany I, Riffon J.

Can Commun Dis Rep. 2019 Jul 4;45(7-8):212-224. doi: 10.45745/ccdr.v45i78a05. eCollection 2019 Jul 4.

3.

High-precision in situ silicon isotopic analyses by multi-collector secondary ion mass spectrometry in olivine and low-calcium pyroxene.

Villeneuve J, Chaussidon M, Marrocchi Y, Deng Z, Watson EB.

Rapid Commun Mass Spectrom. 2019 Oct 30;33(20):1589-1597. doi: 10.1002/rcm.8508.

PMID:
31237970
4.

Correction to: Hypophosphatasia: Canadian update on diagnosis and management.

Khan AA, Josse R, Kannu P, Villeneuve J, Paul T, Van Uum S, Greenberg CR.

Osteoporos Int. 2019 Jul;30(7):1541. doi: 10.1007/s00198-019-05012-8.

PMID:
31143988
5.

Changes in vascular accesses and in incidence rates of dialysis-related bloodstream infections in Québec, Canada, 2011-2017.

Fortin É, Ouakki M, Tremblay C, Villeneuve J, Desmeules S, Parisien N, Moisan D, Frenette C; for SPIN-BAC-HD.

Infect Control Hosp Epidemiol. 2019 Jun;40(6):627-631. doi: 10.1017/ice.2019.65. Epub 2019 Apr 8.

PMID:
30957725
6.

Hypophosphatasia: Canadian update on diagnosis and management.

Khan AA, Josse R, Kannu P, Villeneuve J, Paul T, Van Uum S, Greenberg CR.

Osteoporos Int. 2019 Sep;30(9):1713-1722. doi: 10.1007/s00198-019-04921-y. Epub 2019 Mar 26. Erratum in: Osteoporos Int. 2019 Jul;30(7):1541.

PMID:
30915507
7.

Impact of immigration status on health behaviors and perceptions in cancer survivors.

Liu SY, Lu L, Pringle D, Mahler M, Niu C, Charow R, Tiessen K, Lam C, Halytskyy O, Naik H, Hon H, Irwin M, Pat V, Gonos C, Chan CWT, Villeneuve J, Shani RM, Chaudhry M, Brown MC, Selby P, Howell D, Xu W, Alibhai SMH, Jones JM, Liu G, Eng L.

Cancer Med. 2019 May;8(5):2623-2635. doi: 10.1002/cam4.2079. Epub 2019 Mar 21.

8.

Healthcare-associated bloodstream infection trends under a provincial surveillance program.

Fakih I, Fortin É, Smith MA, Carignan A, Tremblay C, Villeneuve J, Moisan D, Frenette C, Quach C, Schmidt AM; for SPIN-BACTOT.

Infect Control Hosp Epidemiol. 2019 Mar;40(3):307-313. doi: 10.1017/ice.2018.357.

PMID:
30887941
9.

Excess water storage induced by viscous strain localization during high-pressure shear experiment.

Précigout J, Stünitz H, Villeneuve J.

Sci Rep. 2019 Mar 5;9(1):3463. doi: 10.1038/s41598-019-40020-y.

10.

Real-world benefit of nivolumab in a Canadian non-small-cell lung cancer cohort.

Juergens RA, Mariano C, Jolivet J, Finn N, Rothenstein J, Reaume MN, Faghih A, Labbé C, Owen S, Shepherd FA, Villeneuve J, Romeyer F, Pettersson F, Butts C.

Curr Oncol. 2018 Dec;25(6):384-392. doi: 10.3747/co.25.4287. Epub 2018 Dec 1.

11.

Life cycle assessment of the French municipal solid waste incineration sector.

Beylot A, Muller S, Descat M, Ménard Y, Villeneuve J.

Waste Manag. 2018 Oct;80:144-153. doi: 10.1016/j.wasman.2018.08.037. Epub 2018 Sep 10.

PMID:
30454994
12.

Type 3 cytokines IL-17A and IL-22 drive TGF-β-dependent liver fibrosis.

Fabre T, Molina MF, Soucy G, Goulet JP, Willems B, Villeneuve JP, Bilodeau M, Shoukry NH.

Sci Immunol. 2018 Oct 26;3(28). pii: eaar7754. doi: 10.1126/sciimmunol.aar7754.

PMID:
30366940
13.

Patterns, perceptions and their association with changes in alcohol consumption in cancer survivors.

Eng L, Pringle D, Su J, Espin-Garcia O, Niu C, Mahler M, Halytskyy O, Charow R, Lam C, Shani RM, Villeneuve J, Tiessen K, Dobriyal A, Zarrin A, Vennettilli A, Brown MC, Alibhai SMH, Howell D, Jones JM, Selby P, Xu W, Liu G.

Eur J Cancer Care (Engl). 2019 Jan;28(1):e12933. doi: 10.1111/ecc.12933. Epub 2018 Oct 16.

PMID:
30324631
14.
15.

A ten-year review of healthcare-associated bloodstream infections from forty hospitals in Québec, Canada.

Fakih I, Fortin É, Smith MA, Carignan A, Tremblay C, Villeneuve J, Moisan D, Frenette C, Quach C; for SPIN-BACTOT.

Infect Control Hosp Epidemiol. 2018 Oct;39(10):1202-1209. doi: 10.1017/ice.2018.185. Epub 2018 Aug 29.

PMID:
30156168
16.

Soil and land use research in Europe: Lessons learned from INSPIRATION bottom-up strategic research agenda setting.

Bartke S, Boekhold AE, Brils J, Grimski D, Ferber U, Gorgon J, Guérin V, Makeschin F, Maring L, Nathanail CP, Villeneuve J, Zeyer J, Schröter-Schlaack C.

Sci Total Environ. 2018 May 1;622-623:1408-1416. doi: 10.1016/j.scitotenv.2017.11.335. Epub 2017 Dec 13.

PMID:
29890606
17.

Patterns, perceptions, and perceived barriers to physical activity in adult cancer survivors.

Eng L, Pringle D, Su J, Shen X, Mahler M, Niu C, Charow R, Tiessen K, Lam C, Halytskyy O, Naik H, Hon H, Irwin M, Pat V, Gonos C, Chan C, Villeneuve J, Harland L, Shani RM, Brown MC, Selby P, Howell D, Xu W, Liu G, Alibhai SMH, Jones JM.

Support Care Cancer. 2018 Nov;26(11):3755-3763. doi: 10.1007/s00520-018-4239-5. Epub 2018 May 29.

PMID:
29808379
18.

An exploratory case study of the impact of expanding cost-effectiveness analysis for second-line nivolumab for patients with squamous non-small cell lung cancer in Canada: Does it make a difference?

Shafrin J, Skornicki M, Brauer M, Villeneuve J, Lees M, Hertel N, Penrod JR, Jansen J.

Health Policy. 2018 Jun;122(6):607-613. doi: 10.1016/j.healthpol.2018.04.008. Epub 2018 Apr 26.

19.

Correction to: Blood platelets and sepsis pathophysiology: A new therapeutic prospect in critically ill patients?

Dewitte A, Lepreux S, Villeneuve J, Rigothier C, Combe C, Ouattara A, Ripoche J.

Ann Intensive Care. 2018 Feb 28;8(1):32. doi: 10.1186/s13613-018-0378-6.

20.

Unconventional secretion of FABP4 by endosomes and secretory lysosomes.

Villeneuve J, Bassaganyas L, Lepreux S, Chiritoiu M, Costet P, Ripoche J, Malhotra V, Schekman R.

J Cell Biol. 2018 Feb 5;217(2):649-665. doi: 10.1083/jcb.201705047. Epub 2017 Dec 6.

21.

Blood platelets and sepsis pathophysiology: A new therapeutic prospect in critically [corrected] ill patients?

Dewitte A, Lepreux S, Villeneuve J, Rigothier C, Combe C, Ouattara A, Ripoche J.

Ann Intensive Care. 2017 Dec 1;7(1):115. doi: 10.1186/s13613-017-0337-7. Review. Erratum in: Ann Intensive Care. 2018 Feb 28;8(1):32.

22.

A Role for CD154, the CD40 Ligand, in Granulomatous Inflammation.

Villeneuve J, Desmoulière A, Dewitte A, Bordeau N, Costet P, Bassaganyas L, Fricain JC, Ripoche J, Lepreux S.

Mediators Inflamm. 2017;2017:2982879. doi: 10.1155/2017/2982879. Epub 2017 Jul 12.

23.

Hospital-Acquired Methicillin-Resistant Staphylococcus aureus Bloodstream Infections in Québec: Impact of Guidelines.

Li L, Fortin E, Tremblay C, Ngenda-Muadi M, Garenc C, Moisan D, Villeneuve J, Quach C; for SPIN-BACC and SPIN-SARM.

Infect Control Hosp Epidemiol. 2017 Jul;38(7):840-847. doi: 10.1017/ice.2017.81. Epub 2017 Jun 5.

PMID:
28580894
24.

Trends in the use of laboratory tests for the diagnosis of Clostridium difficile infection and association with incidence rates in Quebec, Canada, 2010-2014.

Bogaty C, Lévesque S, Garenc C, Frenette C, Bolduc D, Galarneau LA, Lalancette C, Loo V, Tremblay C, Trudeau M, Vachon J, Dionne M, Villeneuve J, Longtin J, Longtin Y; Quebec Clostridium difficile Infection Surveillance Program (QCISP).

Am J Infect Control. 2017 Sep 1;45(9):964-968. doi: 10.1016/j.ajic.2017.04.002. Epub 2017 May 23.

PMID:
28549882
25.

Early Radiographic and Tomographic Manifestations of Legionnaires' Disease.

Poirier R, Rodrigue J, Villeneuve J, Lacasse Y.

Can Assoc Radiol J. 2017 Aug;68(3):328-333. doi: 10.1016/j.carj.2016.10.005. Epub 2017 May 4.

PMID:
28479105
26.

CD40 signaling and hepatic steatosis: Unanticipated links.

Lepreux S, Villeneuve J, Dewitte A, Bérard AM, Desmoulière A, Ripoche J.

Clin Res Hepatol Gastroenterol. 2017 Sep;41(4):357-369. doi: 10.1016/j.clinre.2016.11.002. Epub 2016 Dec 15. Review.

PMID:
27989689
27.

Novel E2 Glycoprotein Tetramer Detects Hepatitis C Virus-Specific Memory B Cells.

Boisvert M, Zhang W, Elrod EJ, Bernard NF, Villeneuve JP, Bruneau J, Marcotrigiano J, Shoukry NH, Grakoui A.

J Immunol. 2016 Dec 15;197(12):4848-4858. Epub 2016 Nov 14.

28.

Golgi enzymes do not cycle through the endoplasmic reticulum during protein secretion or mitosis.

Villeneuve J, Duran J, Scarpa M, Bassaganyas L, Van Galen J, Malhotra V.

Mol Biol Cell. 2017 Jan 1;28(1):141-151. doi: 10.1091/mbc.E16-08-0560. Epub 2016 Nov 2.

29.

CD154 Induces Matrix Metalloproteinase-9 Secretion in Human Podocytes.

Rigothier C, Daculsi R, Lepreux S, Auguste P, Villeneuve J, Dewitte A, Doudnikoff E, Saleem M, Bourget C, Combe C, Ripoche J.

J Cell Biochem. 2016 Dec;117(12):2737-2747. doi: 10.1002/jcb.25571. Epub 2016 May 5.

PMID:
27070919
30.

Focal Adhesion Kinase Inhibitors in Combination with Erlotinib Demonstrate Enhanced Anti-Tumor Activity in Non-Small Cell Lung Cancer.

Howe GA, Xiao B, Zhao H, Al-Zahrani KN, Hasim MS, Villeneuve J, Sekhon HS, Goss GD, Sabourin LA, Dimitroulakos J, Addison CL.

PLoS One. 2016 Mar 10;11(3):e0150567. doi: 10.1371/journal.pone.0150567. eCollection 2016.

31.

Optimizing postoperative care protocols in thoracic surgery: best evidence and new technology.

French DG, Dilena M, LaPlante S, Shamji F, Sundaresan S, Villeneuve J, Seely A, Maziak D, Gilbert S.

J Thorac Dis. 2016 Feb;8(Suppl 1):S3-S11. doi: 10.3978/j.issn.2072-1439.2015.10.67. Review.

32.

Surgical team turnover and operative time: An evaluation of operating room efficiency during pulmonary resection.

Azzi AJ, Shah K, Seely A, Villeneuve JP, Sundaresan SR, Shamji FM, Maziak DE, Gilbert S.

J Thorac Cardiovasc Surg. 2016 May;151(5):1391-5. doi: 10.1016/j.jtcvs.2015.12.040. Epub 2015 Dec 23.

33.

A consumption approach to wastes from economic activities.

Beylot A, Boitier B, Lancesseur N, Villeneuve J.

Waste Manag. 2016 Mar;49:505-515. doi: 10.1016/j.wasman.2016.01.023. Epub 2016 Feb 2.

PMID:
26851169
34.

Economic evaluation of nivolumab for the treatment of second-line advanced squamous NSCLC in Canada: a comparison of modeling approaches to estimate and extrapolate survival outcomes.

Goeree R, Villeneuve J, Goeree J, Penrod JR, Orsini L, Tahami Monfared AA.

J Med Econ. 2016 Jun;19(6):630-44. doi: 10.3111/13696998.2016.1151432. Epub 2016 Mar 1.

PMID:
26850122
35.

[Epileptic seizures and hematemesis in a young patient with sickle cell disease].

Chevalier J, Villeneuve J, Lecapitaine AL, Gros H, Bakir R, Delaval A, Bouldouyre MA.

Rev Med Interne. 2016 May;37(5):367-70. doi: 10.1016/j.revmed.2015.08.005. Epub 2015 Sep 19. French.

PMID:
26387760
36.

Lifestyle Behaviors in Elderly Cancer Survivors: A Comparison With Middle-Age Cancer Survivors.

Niu C, Eng L, Qiu X, Shen X, Espin-Garcia O, Song Y, Pringle D, Mahler M, Halytskyy O, Charow R, Lam C, Shani RM, Villeneuve J, Tiessen K, Brown MC, Selby P, Howell D, Jones JM, Xu W, Liu G, Alibhai SM.

J Oncol Pract. 2015 Jul;11(4):e450-9. doi: 10.1200/JOP.2014.002287. Epub 2015 Jun 9.

PMID:
26060227
37.

Patient preference: a comparison of electronic patient-completed questionnaires with paper among cancer patients.

Martin P, Brown MC, Espin-Garcia O, Cuffe S, Pringle D, Mahler M, Villeneuve J, Niu C, Charow R, Lam C, Shani RM, Hon H, Otsuka M, Xu W, Alibhai S, Jenkinson J, Liu G.

Eur J Cancer Care (Engl). 2016 Mar;25(2):334-41. doi: 10.1111/ecc.12318. Epub 2015 Apr 20.

PMID:
25899560
38.

The role of second-hand smoke exposure on smoking cessation in non-tobacco-related cancers.

Eng L, Qiu X, Su J, Pringle D, Niu C, Mahler M, Charow R, Villeneuve J, Halytskyy O, Lam C, Tiessen K, Brown MC, Howell D, Giuliani ME, Jones JM, Alibhai SM, Goldstein DP, Xu W, Selby P, Liu G.

Cancer. 2015 Aug 1;121(15):2655-63. doi: 10.1002/cncr.29340. Epub 2015 Apr 15.

39.

New frontiers for platelet CD154.

Dewitte A, Tanga A, Villeneuve J, Lepreux S, Ouattara A, Desmoulière A, Combe C, Ripoche J.

Exp Hematol Oncol. 2015 Mar 1;4:6. doi: 10.1186/s40164-015-0001-6. eCollection 2015.

40.

Life Cycle Assessment of mechanical biological pre-treatment of Municipal Solid Waste: a case study.

Beylot A, Vaxelaire S, Zdanevitch I, Auvinet N, Villeneuve J.

Waste Manag. 2015 May;39:287-94. doi: 10.1016/j.wasman.2015.01.033. Epub 2015 Feb 21.

PMID:
25708404
41.

Transarterial embolization therapies for the treatment of hepatocellular carcinoma: CEPO review and clinical recommendations.

Boily G, Villeneuve JP, Lacoursière L, Chaudhury P, Couture F, Ouellet JF, Lapointe R, Goulet S, Gervais N; Comité de l'évolution des pratiques en oncologie.

HPB (Oxford). 2015 Jan;17(1):52-65. doi: 10.1111/hpb.12273. Epub 2014 Jun 24. Review.

42.

Association between proton pump inhibitor use and spontaneous bacterial peritonitis in cirrhotic patients with ascites.

Ratelle M, Perreault S, Villeneuve JP, Tremblay L.

Can J Gastroenterol Hepatol. 2014 Jun;28(6):330-4.

43.

SLY1 and Syntaxin 18 specify a distinct pathway for procollagen VII export from the endoplasmic reticulum.

Nogueira C, Erlmann P, Villeneuve J, Santos AJ, Martínez-Alonso E, Martínez-Menárguez JÁ, Malhotra V.

Elife. 2014 May 19;3:e02784. doi: 10.7554/eLife.02784.

44.

Chronic obstructive pulmonary disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes, prognostic markers, and functional status changes.

Mok M, Nombela-Franco L, Dumont E, Urena M, DeLarochellière R, Doyle D, Villeneuve J, Côté M, Ribeiro HB, Allende R, Laflamme J, DeLarochellière H, Laflamme L, Amat-Santos I, Pibarot P, Maltais F, Rodés-Cabau J.

JACC Cardiovasc Interv. 2013 Oct;6(10):1072-84. doi: 10.1016/j.jcin.2013.06.008.

45.

Hypoglycemia-related emergency department visits and hypoglycemia-related hospitalizations among new users of antidiabetes treatments.

Moisan J, Breton MC, Villeneuve J, Grégoire JP.

Can J Diabetes. 2013 Jun;37(3):143-9. doi: 10.1016/j.jcjd.2013.02.039. Epub 2013 May 29.

PMID:
24070836
46.

Environmental impacts of residual municipal solid waste incineration: a comparison of 110 French incinerators using a life cycle approach.

Beylot A, Villeneuve J.

Waste Manag. 2013 Dec;33(12):2781-8. doi: 10.1016/j.wasman.2013.07.003. Epub 2013 Aug 1.

PMID:
23910245
47.

Kinesin-5/Eg5 is important for transport of CARTS from the trans-Golgi network to the cell surface.

Wakana Y, Villeneuve J, van Galen J, Cruz-Garcia D, Tagaya M, Malhotra V.

J Cell Biol. 2013 Jul 22;202(2):241-50. doi: 10.1083/jcb.201303163. Epub 2013 Jul 15.

48.

Recruitment of arfaptins to the trans-Golgi network by PI(4)P and their involvement in cargo export.

Cruz-Garcia D, Ortega-Bellido M, Scarpa M, Villeneuve J, Jovic M, Porzner M, Balla T, Seufferlein T, Malhotra V.

EMBO J. 2013 Jun 12;32(12):1717-29. doi: 10.1038/emboj.2013.116. Epub 2013 May 21.

49.

PKD controls mitotic Golgi complex fragmentation through a Raf-MEK1 pathway.

Kienzle C, Eisler SA, Villeneuve J, Brummer T, Olayioye MA, Hausser A.

Mol Biol Cell. 2013 Feb;24(3):222-33. doi: 10.1091/mbc.E12-03-0198. Epub 2012 Dec 14.

50.

MEK1 inactivates Myt1 to regulate Golgi membrane fragmentation and mitotic entry in mammalian cells.

Villeneuve J, Scarpa M, Ortega-Bellido M, Malhotra V.

EMBO J. 2013 Jan 9;32(1):72-85. doi: 10.1038/emboj.2012.329. Epub 2012 Dec 14.

Supplemental Content

Loading ...
Support Center